معرفی
Dr. Maryam Lustberg is a Professor of Internal Medicine (Medical Oncology) at Yale School of Medicine, serving as Director of the Center for Breast Cancer and Chief of Breast Medical Oncology at Yale Cancer Center. She is a nationally recognized leader in breast cancer treatment and research, with a focus on improving long-term outcomes for patients through biomarker discovery and addressing treatment-related side effects. Dr. Lustberg holds an MD from the University of Maryland and an MPH from The Ohio State University, where she also completed residency and fellowship training.
Her research emphasizes novel blood-based biomarkers for recurrence detection and toxicity prediction, with active involvement in cooperative groups like ALLIANCE and SWOG. She has published over 140 peer-reviewed works and received multiple awards for mentorship and clinical excellence. Dr. Lustberg is actively engaged in national organizations including ASCO and MASCC, focusing on patient-centered care and clinical trial engagement.
Key collaborations include work with Lajos Pusztai, Cary Gross, and Eric Winer on breast cancer biology and survivorship. She leads clinical trials evaluating therapies like dapagliflozin in breast cancer and circulating tumor DNA-guided adjuvant treatments. Her work bridges translational research with clinical practice to enhance patient outcomes and reduce treatment-related morbidity.